Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127542211 | 12754221 | 1 | I | 20160603 | 20160915 | 20160915 | EXP | US-ASTRAZENECA-2016SE60786 | ASTRAZENECA | 0.00 | F | Y | 57.60000 | KG | 20160915 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127542211 | 12754221 | 1 | PS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | 200.0MG UNKNOWN | 22047 | 200 | MG | PROLONGED-RELEASE TABLET | |||||||
127542211 | 12754221 | 2 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | 200.0MG UNKNOWN | 22047 | 200 | MG | PROLONGED-RELEASE TABLET | |||||||
127542211 | 12754221 | 3 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | 200.0MG UNKNOWN | 22047 | 200 | MG | PROLONGED-RELEASE TABLET | |||||||
127542211 | 12754221 | 4 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | 50.0MG UNKNOWN | 22047 | 50 | MG | PROLONGED-RELEASE TABLET | |||||||
127542211 | 12754221 | 5 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | 50.0MG UNKNOWN | 22047 | 50 | MG | PROLONGED-RELEASE TABLET | |||||||
127542211 | 12754221 | 6 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | 50.0MG UNKNOWN | 22047 | 50 | MG | PROLONGED-RELEASE TABLET | |||||||
127542211 | 12754221 | 7 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Unknown | GENERIC QUETIAPINE FUMARATE; 150MG TWICE DAILY. UNKNOWN | 22047 | ||||||||||
127542211 | 12754221 | 8 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Unknown | GENERIC QUETIAPINE FUMARATE; 150MG TWICE DAILY. UNKNOWN | 22047 | ||||||||||
127542211 | 12754221 | 9 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Unknown | GENERIC QUETIAPINE FUMARATE; 150MG TWICE DAILY. UNKNOWN | 22047 | ||||||||||
127542211 | 12754221 | 10 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | 100.0MG UNKNOWN | 22047 | 100 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
127542211 | 12754221 | 11 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | 100.0MG UNKNOWN | 22047 | 100 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
127542211 | 12754221 | 12 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | 100.0MG UNKNOWN | 22047 | 100 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
127542211 | 12754221 | 13 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | 75 | UG | QD | |||||||||
127542211 | 12754221 | 14 | C | TESTOSTERONE. | TESTOSTERONE | 1 | 0 | ||||||||||||
127542211 | 12754221 | 15 | C | PROGESTERONE. | PROGESTERONE | 1 | 0 | ||||||||||||
127542211 | 12754221 | 16 | C | ESTROGEN | ESTRONESUS SCROFA OVARY | 1 | 0 | ||||||||||||
127542211 | 12754221 | 17 | C | ATIVAN | LORAZEPAM | 1 | 0 | 5 | MG | QID | |||||||||
127542211 | 12754221 | 18 | C | VISTRAL | 2 | 0 | 50 | MG | Q4H |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127542211 | 12754221 | 1 | Bipolar disorder |
127542211 | 12754221 | 2 | Anxiety |
127542211 | 12754221 | 3 | Insomnia |
127542211 | 12754221 | 4 | Bipolar disorder |
127542211 | 12754221 | 5 | Anxiety |
127542211 | 12754221 | 6 | Insomnia |
127542211 | 12754221 | 7 | Bipolar disorder |
127542211 | 12754221 | 8 | Anxiety |
127542211 | 12754221 | 9 | Insomnia |
127542211 | 12754221 | 10 | Bipolar disorder |
127542211 | 12754221 | 11 | Anxiety |
127542211 | 12754221 | 12 | Insomnia |
127542211 | 12754221 | 13 | Hormone replacement therapy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127542211 | 12754221 | HO |
127542211 | 12754221 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127542211 | 12754221 | Anxiety | |
127542211 | 12754221 | Concussion | |
127542211 | 12754221 | Condition aggravated | |
127542211 | 12754221 | Crying | |
127542211 | 12754221 | Dehydration | |
127542211 | 12754221 | Off label use | |
127542211 | 12754221 | Product use issue | |
127542211 | 12754221 | Therapeutic response changed |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127542211 | 12754221 | 7 | 1984 | 0 | ||
127542211 | 12754221 | 8 | 1984 | 0 | ||
127542211 | 12754221 | 9 | 1984 | 0 |